JENNIFER O'FLARITY: Open Payments
NPI 1194395020 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 23 payments from 9 companies in 2025. Trend: 2023 $221 · 2024 $324 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $191 |
| Medtronic, Inc. | 1 | $100 |
| Novo Nordisk Inc | 1 | $62 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $53 |
| ConvaTec Inc. | 1 | $34 |
| Organogenesis Inc. | 1 | $26 |
| Innovation Technologies Inc | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $14 |
Products named: GATTEX, PROGRIP, Wegovy, JOURNAVX, AQUACEL AG+ EXTRA, AFFINITY, IRRISEPT, Exparel.
Industry payments across MS — which companies pay providers there.
